[{"Assets_0_Q1_USD":678924000.0,"CommonStockSharesOutstanding_0_Q1_shares":50697471.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-100635000.0,"NetIncomeLoss_1_Q1_USD":-77694000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":18523000.0,"StockholdersEquity_0_Q1_USD":306236000.0,"Ticker":"CLVS","CIK":"1466301","name":"CLOVIS ONCOLOGY, INC.","OfficialName":"Clovis Oncology Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"317205570.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180509"}]